To hear about similar clinical trials, please enter your email below
Trial Title:
Evaluation of Study Experiences of Neuroendocrine Tumor Patients
NCT ID:
NCT05967481
Condition:
Neuroendocrine Tumors
Conditions: Official terms:
Neuroendocrine Tumors
Conditions: Keywords:
neuroendocrine tumor
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Taking part in clinical trials usually favors a particular demographic group. But there
is limited research available to explain what trial attributes affect the completion of
these specific demographic groups.
This research will admit a wide range of data on the clinical study experience of
neuroendocrine tumor patients to determine which factors prevail in limiting a patient's
ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future patients
with neuroendocrine tumor.
Criteria for eligibility:
Study pop:
Patients with neuroendocrine tumor who are actively considering enrolling in a clinical
study, but have not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patient is at least 18 years of age
- Diagnosis of neuroendocrine tumor
- Ability to understand and the willingness to sign a written informed consent
document
Exclusion Criteria:
- Enrolled in another research study
- Patients with psychiatric illness/social situations that would limit compliance with
study requirements
- Pregnant or lactating woman
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
August 2024
Completion date:
August 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05967481
